Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in patients with symptomatic hypertrophic cardiomyopathy
2011-004507-20Phase 2Completed
- Sponsor
- Menarini Group
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertrophic cardiomyopathy (HCM) comparing Ranolazine with Placebo (2 arms). Primary endpoint: Exercise capacity by peak oxygen consumption. Started Oct 2011; status: completed.
02
Drugs
ranolazine
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on 2011-004507-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004507-20.